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ABSTRACT 
ST Monitoring on the Programmer for Implantable Cardioverter Devices  
Sarina Satya  
Cardiovascular disease is one of the most prevalent causes of death. However, if 
cardiovascular disease is identified early and treated appropriately, the mortality in 
patients with cardiovascular disease can be hugely reduced. For several decades, 12-Lead 
ECG has been the standard technique used to identify ischemia, and recent studies have 
shown that intracardiac electrogram has many benefits over external monitoring such as 
holter. ST Monitoring feature has been added to St. Jude Medical intracardiac 
cardioverter defibrillators (ICD) to leverage the ECG technology for identifying 
cardiovascular disease. This algorithm monitors the intracardiac electrogram to detect 
and report patterns which could be related to ischemic events. This feature is expected to 
enhance the process of identifying ischemia and infarction, and provides long-term 
management of the disease. 
In order to support the new implantable devices with ST Monitoring capability, 
the programmer software was updated to support this new feature in the device. This 
thesis discusses the work on the programmer. Chapter 1 begins with a background of how 
monitoring technology in an implantable device can benefit the patients facing high risk 
of myocardial infarction. Chapter 2 states the objective for the work on the programmer.  
Chapter 3 describes the implementation and the application of this feature. Conclusion 
and future development are discussed in Chapter 5. 
Keywords: Merlin.net, St. Jude Medical, Cardiac Device, ST Monitoring 
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I. INTRODUCTION 
Cardiovascular disease is the number one cause of death globally. According to 
the World Health Organization, this disease claims more than 17 million lives a year, 
representing 30% of all global deaths [1].  In the United States, there are 1.26 million 
cases of recurrent coronary attack each year, out of which 37% of the people die within a 
year [2]. 
 
 
Figure 1 Heart Disease and Stroke Statistics [3] 
 
Although cardiovascular disease is prevalent and mortality rate is high, many 
studies have confirmed that if heart diseases symptoms are identified early, it is possible 
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to minimize the development of the disease, reduce the risk of heart attack, and increase 
the mortality in patients with heart disease. However, many patients with heart diseases 
do not receive timely treatment. During early stage of the disease, many patients do not 
feel any symptoms for a long time and no treatment or preventive measure is given until 
the problem develops into a life threatening stage [4]. Also, when patients with acute 
symptoms are in the hospital, there is still a need to improve the time taken to diagnose 
the disease which would hugely impact the morbidity and mortality of the patients [11] 
Patients who are dependent on implanted device are facing the highest risk of 
such disease, and EGM patterns have been known to be the best tool to identify their 
heart anomalies such as ischemia. Therefore, St. Jude Medical collaborated with Angel 
Medical Systems to co-develop an algorithm to monitor heart beats from an implanted 
device. This algorithm monitors the intracardiac EGM to detect and report patterns found 
in the patient that could be indicators of symptoms. These systems indicate severe heart 
disease which could lead to fatal ventricular fibrillation or infarction. With an implanted 
device, these patterns can be easily detected even in patients that are asymptomatic. This 
feature, called ST Monitoring, is expected to be hugely beneficial to these patients, 
provided that approximately 70 – 90 % of all ischemia detectable with EGM is silent [4].   
This chapter will provide a background of the heart and the foundation of using 
the intracardiac EGM for diagnosing heart diseases. Following that discussion there will 
be an overview of the benefits of an implantable device that provides chronic monitoring 
of the ST-Segment. 
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Physiology of the heart 
The human heart is a powerful muscular pump. It contracts seventy times per 
minute on average and pumps about five liters of blood each minute to all organs and 
tissues. The body needs the oxygen in the blood to carry out normal functions. The 
circulation of blood also removes waste from those organs and tissues, and delivers 
deoxygenated blood to the lungs. This is also crucial for the body to carry out normal 
functions.  
The heart has four chambers, two on the left side and two on the right side. The 
two top chambers are known as the right and left atrium, and the two bottom chambers 
are the right and left ventricles. The right and the left chambers are separated by a wall 
called the septum.  
The heart is connected to a few large blood vessels which serve as the routes for 
blood to flow in and out of the heart.  There are two major types of blood vessels: arteries 
and veins. The arteries carry blood from the heart to the body, and the veins carry blood 
from the rest of the body back to the heart.  For example, the aorta artery carries nutrient 
rich blood away from the heart while the superior vena cava and the inferior vena cava 
take the blood from the rest of the body into the right atrium. The pulmonary artery 
carries oxygen depleted blood from the heart to the lung, and the pulmonary veins take 
blood from the lungs to the left atrium.  
In addition, the heart comes with valves that prevent blood from flowing in the 
wrong direction. These valves are fibrous tissues found between the atria and the 
ventricles, as well as between the great arteries and at the top of the ventricles. The mitral 
valve connects the left atrium with the left ventricle, and the tricuspid valve connects the 
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right atrium with the right ventricle.  The aortic valve and the pulmonary valve are found 
at the base of the corresponding arteries.  
 
Figure 2 The Heart [25] 
 
On the outside, the heart is wrapped around by the pericardium and on the inside 
it is covered by a smooth lining called the endocardium. The middle layer, which is the 
thickest layer of the heart, is made up of a special type of muscle called cardiac muscle or 
myocardium.  
As shown in Figure 3 below, the cardiac muscle cells are striated, with muscle 
fibers parallel to each other branched and joined at various locations resulting in 
intercalated disks that form a functional network. The pumping action of the heart is the 
result of coordinated contraction of these cardiac muscles in the heart. 
Unlike the skeletal muscles, which contract in response to the stimulus from the 
nerve terminals attached to them, the cells in the cardiac muscles pass electrical impulses 
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to their neighbors through special channels called gap-junctions.  The heart only needs to 
be stimulated at one location and the electrical impulses get passed on to the rest of the 
heart muscle, causing it to contract. 
 
Figure 3 Cardiac muscle characteristics [25] 
Action potential in the cardiac muscleF 
Electrical impulses in the heart cause action potential, which is “the change in 
membrane potential occurring in nerve, muscle, or other excitable tissue when excitation 
occurs” [17]. Action potential results in the contraction of the cardiac muscle and initiates  
the pumping action of the heart, and the electrical mechanism associated with action 
potential provides a way to identify abnormal heart function. 
The cell membrane of cardiac muscle is permeable to the ions of elements that are 
important to the functioning of the heart. The three main elements are potassium, 
calcium, and sodium. There are “gates”, or ion channels, on the cell membrane that 
control the movement of these charged elements in and out of the cell. As a result of the 
movement of these ions across the cell membrane, there is a difference in electrical 
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potential between the inside and outside of a cell, and that is called the membrane 
potential.  
 The cells in the cardiac muscle can either be resting or electrically stimulated.  A 
cardiac cell that is not stimulated by an electrical impulse is called a resting cardiac cell. 
It has less positive charges inside than outside, so the net electrical potential across the 
cell membrane is negative. When a cardiac cell receives an electrical stimulus from an 
adjacent cell, it is electrically stimulated. The ion channels open and rapid influx of the 
sodium ions results in depolarization of the cell and causes the cell to contract.  
After depolarization and contraction, the cardiac cells repolarize as positive 
potassium ions (K+) are pumped out of the cells. The cells return to negative potential. 
When the cardiac cells are repolarizing, the cells are in refractory and cannot depolarize. 
The movement of charged ions causes an electrical current which gets transmitted to the 
adjoining cell and causes it to contract. This depolarization and repolarization continues 
across a large scale of cardiac muscle contraction leading to the pumping action of the 
heart’s chamber. 
The diagram below shows the different phases of action potential that correspond 
to the voltage changes that are present.  
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Figure 4 Cardiac Action Potential Phases [18] 
 
The cardiac action potential lasts over 300 msec, which is about fifteen times 
longer than the skeletal muscle action potential, and it consists of five phases. As 
described above, the phases of the action potential are associated with the movement of 
the charged ions across the cell membrane. The upstroke in Phase 0 corresponds to rapid 
depolarization due to a rapid influx of Na+ ions through the fast sodium channels. These 
channels close abruptly after only a small fraction of a second, and abruptly decrease the 
permeability of sodium across the cell membrane, and the net outward movement of the 
potassium ions causes the cross membrane voltage to decline in Phase 1. In Phase 2, the 
plateau in voltage changes is due to a balance between inward flow of calcium ions and 
outward flow of potassium ions. The calcium channels close at the end of the plateau, 
while the potassium channels remain open. The net outward flow of potassium ions 
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causes a fall in the membrane potential which characterizes the depolarization in Phase 3.  
The voltage continues to decrease until it reaches the resting membrane potential 
represented by Phase 4.  The cycle repeats when the next electrical stimulus occurs. 
 
The Cardiac Cycle  
The electrical impulses that are transmitted through the atrium and ventricles 
cause coordinated contraction of the cardiac muscles and the pumping action of the heart, 
which is known as the heartbeat. The sequence of events that occurs through the heart 
from the beginning of one heartbeat to the beginning of the next is known as the cardiac 
cycle. 
 
 
 
Figure 5 Cardiac Cycle [19] 
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As shown in the diagram above, the cardiac cycle consists of two different stages. 
During the diastole stage the atria or ventricle relax and fill with blood, while during the 
systole stage, the muscles of the atria or ventricle contract and pump blood out.  
The heart contains pacemaker cells, such as the collection of cells at the sinoatrial 
node, which can initiate electrical impulses rhythmically. In the beginning of the cycle, 
the sinoatrial node depolarizes and initiates an action potential and the atria contracts. 
The action potential travels through the A-V bundle and is delayed for about a small 
fraction of a second before entering into the ventricles causing the ventricles to contract. 
As a result, the atria contract ahead of the ventricle and fill the ventricles with blood 
before ventricular contraction begins.  
Electrocardiogram and the cardiac cycle 
The electrical activity throughout the cardiac cycle can be measured by electrodes 
placed on the surface of the skin, or by more invasive method such as catheter or 
implantable pacemaker or an implantable cardioverter defibrillator (ICD). The voltage 
between pairs of these electrodes, from different directions, is often referred to as the 
vectors. They are also referred to as leads. Electrocardiogram is the recording and 
graphical presentation of such electrical activity over time.  
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Figure 6 Normal Electrogram 
 
The electrogram in the above figure shows the electrical activity of a normal 
ventricular muscle fiber during normal function. The P, QRS, and T waves correspond to 
different stages of the cardiac cycle. The P wave represents depolarization of the atria, 
and the QRS waves represent the depolarization of the ventricles, which is slightly before 
the onset of ventricular systole.  The T wave represents the stage of repolarization of the 
ventricles, when the ventricles begin to relax.  
Electrocardiogram and cardiac diseases 
 Abnormalities or disease of the heart can change the electrical signal conduction 
pattern and cause abnormal electrical potentials around the heart. In a study done by 
Kleber and his co-workers [6], transmembrane potentials from pig ventricular cells were 
recorded before and after occlusion of the left anterior descending artery. This study 
reported the observation of  extracellular potassium activity increased from 4 mM to 
around 14.7 mM during 15 minutes of ischemia. A few years later, another study also 
provided similar observation [10]. This study was done on 11 open chest dogs during a 
30 min ligation of the left anterior descending coronary artery, and extracellular K+ 
changes during acute myocardial in the ischemic zone and normal myocardium were 
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measured. Before coronary ligation, extracellular K+ ranged from 4.0 +/- 0.3 to 4.3 +/- 
0.3 mM in the extracellular zone. After ligation, extracellular K+ accumulated in the 
ischemic reached 9.8 +/- 2.0mM, while the central ischemic zone reached a much higher 
level (14.4 +/1 4mM). In contrast, no significant changes in K+ occurred in the normal 
zone throughout the ischemic period.   These studies suggested that relative potassium 
permeability predominates during ischemia, which leads to an increase in extracellular 
K+, resulting in abnormal membrane potential in the ischemic tissue  and membrane 
depolarization.  In addition, it has also been found that an extracellular current, known as 
current of injury, was found flowing from the injured epicardial border zone towards 
normal myocardium[22]. 
The current of injury is the result of the damaged heart tissues being partially or 
totally depolarized all the time. Excessive extracellular K+ in the injured tissue causes an 
abnormal potential gradient at the extracellular area between the injured zone and the 
normal zone. This potential gradient causes a current to flow from the injured areas 
towards the normally polarized areas. When this current of injury is detected by the 
electrocardiogram, the ST-segment and the TQ segment on the electrocardiogram will 
appear to be shifted.  
Ischemia is a common cause of current of injury. During ischemia, normal 
membrane polarization cannot be maintained due to lack of blood supply and other 
nutrients. As a result of this current of injury, ST-segment elevation is commonly 
observed on the EGM collected from patients with ischemia.  
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Figure 7 Current of injury in electrocardiogram [19] 
 
In addition, Kebler’s study also found that there was an increase in extracellular 
potassium accumulation occurred when heart rate was increased abruptly from 60 to 170 
beats/min [6]. The effect of an abrupt change in heart rate was observed during three 
different time intervals: prior to occlusion, during occlusion, and during reperfusion. In 
the diagram below, the heart rate was increased abruptly from 60 beats per minute to 170 
beats per minute for the times indicated by the bars. 
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Figure 8 Extracellular K+ activity [6] 
 
 
 
As shown in the diagram, when the heart rate was increased abruptly from 60 to 
170 beats per minute, there was a more pronounced increase in K+ accumulation.  
Many studies have been conducted to gain deeper understanding of the 
mechanisms of the potential difference in cardiac tissues during ischemia. It has been 
suggested that the cellular loss of potassium is largely due to the opening of ATP-
sensitive K+ channels. Blockers for the Katp channels were found to partially prevent 
action potential shortening and extracellular K+ accumulation. [5, 7, 8, 9] 
ST-segment monitoring and Ischemia Detection 
Ischemia can be symptomatic, asymptomatic, consistent, or unstable.  All types of 
ischemia can be related to the interruption of action potential and delayed or obstructed 
conduction through the cardiac muscle. Because interruption of the electrical conduction 
in the cardiac muscle can result in the alteration of ST-segment on the ECG waveform, 
objective evidences of myocardial ischemia may be obtained from monitoring the ST 
segment changes 
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ST-segment elevated ischemia is a common cause of myocardial infarction. 
Myocardial infarction is commonly classified as STEMI, which is marked by an 
elevation of the ST segment, or NSTEMI, which is not. A recent report from the National 
Center for Health Statistics showed that 500,000 out of 896,000 of hospitalizations due to 
MI are related to a shift in ST-segment [13]. 
 
Figure 9 Possible STEMI electrocardiogram [14] 
 
 
12-Lead electrocardiography, vectocardiography, and ambulatory 
electrocardiogram are common and effective methods for identifying ST-segment 
elevation.  These methods provide important information to guide management and 
determine prognosis, which are critical in reducing the time to treatment for the patients. 
[12].  
Recent publications have also confirmed the feasibility of using subcutaneous 
electrodes on implanted devices. Such devices are already being used for detecting other 
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cardiac events, such as ventricular fibrillation [20].  These studies have also shown that in 
many ways, implanted devices can be used for the detection of ischemia and provide 
superior ST-segment monitoring result.  Some obvious benefits of using implanted device 
for ST-segment monitoring are as follows: 
(1) For patients who have previous infarction and are at higher risk of recurrent 
infarction, ST monitoring feature in an implanted device could provide early detection of 
a serious myocardial infarction and timely notification. The OPTIMAAL trial showed 
that the majority of sudden deaths (57%) were due to recurrent infarction[21]. The 
MADIT II study has also shown that implanted defibrillator improves survival for 
patients with prior myocardial infarction.   
 (2) Many ICD patients also suffer advance state of cardiac diseases such as 
coronary artery disease and left bundle-branch block. For these patients, this feature will 
provide important diagnostic information including chronic intracardiac EGM and events 
summary information immediately. This information can be used to differentiate ST-
segment deviation that results from conditions other than myocardial infarction and avoid 
unwarranted thrombolytic therapy or emergency angiograph. In the case of acute 
myocardial infarmtion, such information can shorten time to treatment in case of critical 
events such as ventricular fibrillation or identify other complicaqtion such as ventricular 
aneurism. Since the majority of deaths from myocardial infarction occur within the first 
one to two hours after symptom onset, ACC/AHA 2004 Guidelines for the Management 
of Patients with ST-elevation Myocardial Infarction recommends to keep ischemic time 
to within 120 minutes and medical contact to balloon (i.e. treatment with percutaneous 
coronary intervention) time within 90 minutes.  
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 (3) Patients with coronary artery disease often develop changes over the course 
of the disease. With implanted device that monitors the ST-segment, changes can be 
tracked in the ischemic profile of these patients to enable early treatment and reduce 
future cardiac events. 
(4) Monitoring ST-segment changes using holter monitoring is cumbersome. 
Multiple electrodes and their associated wires need to be managed, and may affect the 
quality of life for the patients.   An implanted device does not require skin electrodes, and 
external wires. In addition, noise and baseline can be controlled more effectively in an 
implanted device than holter monitor.  
(5) ST-segment monitoring feature in an implanted device may be connected to 
remote monitoring system. With current state-of-the-art wireless technology, diagnostic 
data, including related EGM, can be extracted from the implanted device remotely and 
sent to a remote patient database for storage. The data can be made available to the 
physician in a timely manner as well as for future reference.  
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II. OBJECTIVE 
The objective of this project is to update the existing programmer software to 
extract and interpret the ST Monitoring data from the implanted device, as well as 
provide an interface for adjusting the feature in the device. The development of the ICD 
ST Monitoring firmware started in 2007, and the programmer software had to be updated 
to make the ST Monitoring diagnostics data available to physician. 
To accomplish this objective, understanding the requirement and the programmer 
software thoroughly is critical, because the programmer software was updated according 
to the requirement. In addition, it is also important to understand the programmer 
software structure and the techniques used to develop the programmer software. This 
chapter will first provide a high level discussion of the requirement for the programmer 
ST monitoring feature, following that this chapter will provide an overview of the 
existing programmer application software. 
Requirements for the Programmer Application  
 External Instruments Interface Specification (EIIS):  
The interface between the programmer and the implantable device is defined in a 
set of requirement documents called the External Instruments Interface 
Specification (EIIS). This document provides information including the 
following:  
•  physical layout of the data in the device 
•  mechanism to retrieve the data 
• formulae to interpret the data, and  
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• Procedures to get the device to perform required functionality. 
 Programming Logic Requirements Specification (PLRS) 
Parameters provide meaningful information representing the current state of the 
device. Most of these parameters also correspond to the information presented on 
the programmer screen and some of these parameters can be programmed from 
the programmer screen. The full list of these parameters, and the related display 
and logical usage of these parameters are found in the requirement called the 
Programming Logic Requirement Specification (PLRS). This requirement also 
provides the formulae for correlating these parameters with the information 
retrieved from the device.  
 Use Case: Feature requirement 
The behavior of features supported by the programmer is defined in various Use 
Case Requirements. There is one corresponding Use Case Requirement for each 
feature. For example, there is one use case for implanted device connection, a 
separate use case for managing the programmable parameters, and a separate use 
case for ST Monitoring, and so forth. 
ST Monitoring Use Case on the programmer 
The programmer is responsible for extracting the ST Monitoring data from the 
implanted device. This is done during initial interrogation during a patient follow-up 
session. The data read is interpreted and displayed on the ST Monitoring Workspace of 
the programer. This workspace also provides the ST Monitoring Setup window which 
can be used to program the parameters related to this feature. The ST Monitoring 
workspace provides graphical display of the diagnostics in three different groups: ST 
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Deviation Trend; ST Episode Log, and ST Histogram Data, and each of these groups 
present information pertaining to four different heart rate zones. 
 ST Monitoring Heart Rate Zones 
ST Monitoring diagnostics data are collected from four different heart rate 
zones: Resting Heart Rate Zone, Elevated 1 Heart Rate Zone, Elevated 2 Heart 
Rate Zone, and Elevated 3 Heart Rate Zone. Each zone is defined by a set of 
maximum and minimum beat-per-minute. The resting zone can be programmed to 
different values by the user via the programmer while the boundaries for the other 
heart rate zones are adjusted automatically by the programmer.  
 ST Monitoring Deviation Trend 
This information consists of the deviation of the ST segment compared to 
the isoelectric segment over a period of time. These deviations can be displayed 
graphically on the programmer as a trend. The deviation trend for all four 
different heart rate zones are all retrieved from the device. The programmer 
application converts the raw value to displayable value in “mV” unit. The 
maximum ST Deviation during the sampling period is also calculated by the 
programmer. 
 ST Monitoring Episode Log 
When an elevation or depression of the ST-segment is detected and the 
shift exceeds the programmed thresholds, the device will store summary 
information related to each of the incidences. This information is grouped 
together and summarized in an ST episode. The information captured includes the 
following: 
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• ST Episode Heart Rate at onset (bpm) 
• Max ST Shift (%) 
• ST Episode Duration (D:H:M:S) 
• Stored EGM 
 
The device stores up to 90 ST episodes. However, only the oldest and the 
most recent 29 episodes are displayed on the programmer screen.  In addition, 
only the oldest and four of the most recent ST episodes will be provided with 
associated stored EGM. The stored EGMs are collected from a wideband channel 
with RVtip to Can configuration. Additional processing by the programmer 
application is required before they are displayed. New VT/VF Episodes within 15 
Minutes of any ST Episode are also collected and displayed on the same 
workspace.  
 ST Monitoring Histogram 
The ST Histogram contains the total number of beats for each previously 
defined ST deviation range in each of the four heart rate zones. The histogram 
data are collected over time, and displayed graphically on the programmer screen 
during a patient follow-up session.   
 ST Monitoring Setup Parameters 
ST Monitoring Setup Parameters hold the values used by the device for 
the detection of ST deviation and ST Episode. These parameters can be 
programmed by the user to different values from the ST Monitoring workspace. 
These parameters include the following: 
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• Isoelectric Start: This parameter determines the starting point for the 
isoelectric interval for each heart rate zone. 
• Isoelectric duration: This parameter determines the time period of the 
isoelectric interval for each heart rate zone. 
• ST Start: This parameter determines the starting point for the ST 
interval for each heart rate zone. 
• ST Duration: This parameter determines the time period of the ST 
interval for each heart rate zone. 
• Positive Threshold: This parameter sets the positive threshold for each 
heart rate zone. 
• Negative Threshold: This parameter sets the negative threshold for 
each heart rate zone.  
 
 ST Monitoring Suggested Thresholds 
For the positive and negative threshold values, the ST Monitoring feature 
provides suggested values for each heart rate zone. The programmer application 
calculates the values based on the ST Histogram data using an algorithm 
developed from past clinical studies. 
  
Programmer Application 
St. Jude Medical Programmer is a computer application that provides clinicians the 
option to interact with the implantable pulse generators and defibrillator products.  The 
programmer application is responsible for communicating with the devices via a 
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telemetry wand or other communication technology. User interface with the Programmer 
includes touch screen, external keyboard, and the console buttons on the programmer. 
On the programmer screen, users can view all the data retrieved from the device, 
including the current settings for all the features, diagnostics data collected over time, and 
current device status such as the battery longevity. Other actions that can be performed 
by the user include performing clinical tests on the device and viewing the results, 
programming parameters to different values, viewing the stored EGMs, and printing 
reports.  
The following section provides an overview of the programmer application structure 
and various software development techniques used in building this application. The 
implementation of the ST Monitoring feature is based on the existing architecture of the 
programmer and similar development techniques.  
The programmer application is organized in three layers:  User Interface layer, 
Business Logic layer, and Device Data Layer. Each of these layers consists of one or 
more sub-systems. For example, the data layer consists of the Device Sub-System, the 
Communication Sub-System, and the Streaming Data Sub-System. Each of these sub-
systems is composed of smaller components. The release of the programmer application 
consists of all three layers packaged together.  
The programmer application development can be classified broadly as framework 
development and application extension development. The framework consists of java 
classes that support the function of the application extension, while the application 
extension consists of java classes which support the use cases.  Both framework and 
application extension are partitioned into the same components and same subsystems as 
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described above. The sub-systems interface with each other by Application 
Programmable Interfaces (APIs) or pre-defined events. 
At the beginning of each patient follow-up session, each of the sub-systems is 
responsible for performing any necessary initialization for that sub-system.  Similarly, 
when a patient follow-up session ends, each of the sub-system is responsible for 
performing any necessary clean-up for that sub system. 
 
 Device Sub System (DSS) 
The DSS is responsible for creating the logical representation of a specific device 
model and all of its features during a session. It consists of static models that can 
be used to create the logical representation of the implanted device when one is 
connected to the other. The DSS is also responsible for reading the raw device 
data and interpreting the data such that it is meaningful for other sub-systems.  In 
addition, the DSS provides services that trigger various actions in the implanted 
device. These services include program parameters, read or clear diagnostics data, 
initiate or terminate clinical tests in the device, and download updated firmware to 
the device.  
 
 Communication Sub System (DSS) 
The Communication Subsystem (CSS) is a subsystem within the data layer which 
provides the capability to establish connections with the implantable device. It 
encapsulates the details of a connection, such as the communication protocol, 
from other subsystems in the application. CSS creates unique representation of 
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each connection, and provides all the services needed to establish and control 
each of the connections.  
 
 Streaming Data System (DSS) 
The Streaming Data Subsystem (SDSS) is another subsystem within the data layer 
which is responsible for managing and controlling data streams such as the 
surface EGM, stored EGM, and marker data retrieved from the implanted device. 
It also provides services to manipulate the data such as heart rate calculation, 
ECG filtering and annotation, marker decoding, and taking freeze capture of the 
data stream. 
 
 Graphical User Interface Sub System (GSS) 
The GUI subsystem in the GUI layer is responsible for the look and feel of the 
programmer screen as well as all the graphical display of the device data. It is also 
responsible for providing appropriate actions in respond to user interaction on the 
screen.  
 
 Business Process Sub System and Business Rule Sub System (BPSS and BRSS) 
The Business Process sub system (BPSS) is responsible for representation of 
application logic. All the business processes collaborate with each other and with 
the other sub systems. They map the user request from the GUI to appropriate 
actions in other sub systems, and trigger a GUI update when those actions are 
complete. The Business Rule sub system is responsible for enforcing logical data 
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integrity when data is changed. For example, when a user selects a different value 
for a particular parameter on the GUI, the Business Rule sub-system will check 
for possible conflicts with the programmed value of all other parameters. If a 
conflict is found, the GUI sub-system is notified and the conflict will be shown on 
the screen to inform the user. 
 
 Software language : Java and OOP 
The programmer application is written using the Java programming language and 
Object Oriented Programming (OOP) technique. OOP is a software development 
technique which is based on the states and activities of real world objects. The 
programmer application is built upon the following Java and OOP concepts: 
1. Class:  In Java language, a class contains the definition of structure, 
characteristics, and behavior of a particular thing. It is the blueprint 
from which an instance of the thing is created. 
2. Instance: An instance is one copy of a class. Different instances of the 
same class may have different states at any time when an application is 
running. 
3. Object: An object is an instance of a class. 
4. Thread: A thread is a process, or a single sequential flow of actions 
within an application. Java supports running multiple threads at the 
same time within the same application process, which makes the 
execution of tasks faster and more efficient. 
 
 Software design patterns 
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The programmer software applied many software design patterns including the 
following: 
1. Type-Object pattern: This is used to separate the objects that hold the 
information loaded from the pre-defined (or static) model of the 
implanted device from the objects that hold and process information 
that are only available during the application run time.   
2. Finite State Machine (FSM) pattern: This pattern represents the flow 
of a process in a finite number of states. Each FSM has a start state and 
an end state and can be run as a separate thread. Therefore all the 
FSMs can be executed asynchronously. Within an FSM, the transition 
from one state to another is triggered by events, and the execution 
order of the states is dependent on application runtime conditions. 
Most of the device procedure, such as parameter programming and 
emergency shock, are implemented using FSM. 
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III. IMPLEMENTATION AND RESULTS 
In order for the programmer software to support new devices with the ST 
Monitoring feature, new parameters and new diagnostic models need to be added to the 
programmer software. In addition, new business logic needs to be added to the 
programmer software to process the new type of stored EGM related to the ST 
Monitoring feature. Implementation of a new algorithm for the calculation of the 
recommended ST-Segment thresholds also needs to be added.  
The ST Monitoring project on the programmer was completed in July 2008.  
The results of this project provided the programmer the capability to turn on this feature 
in the implanted device when it is first interrogated and the capability to retrieve all of the 
ST Monitoring diagnostic data from the device during subsequent follow-up sessions. 
The data retrieved and displayed on the programmer allow the clinician to review the 
status of the disease. The data can also be printed to a report in PDF format. User 
interface on the programmer also allows the user to program the parameters to adjust the 
ST Monitoring algorithm.   
As shown in the following screen shot of the programmer, the ST Monitoring 
workspace contains the display of the ST Deviation Trend, ST Deviation Histogram, and 
the ST Episode Log summary [15]. The “GOTO Setup Button” will bring up additional 
windows on which the user can review or program the ST Monitoring parameters.   
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Figure 10 ST Monitoring Workspace 
 
ST Monitoring parameters setup on the programmer 
The programmer screen for the ST monitoring parameters settings are grouped 
under these four tabs: Isoelectric, ST Interval, Positive Threshold, and Negative 
Threshold. The user can change these values by touching the parameter panel on the 
screen. The diagram below shows the screen shot setting up the negative thresholds. 
Other screen shots for these windows can be found in the APPENDIX.  
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Figure 11 Threshold Setup 
 
When the user selects the parameter panel under any of the four tabs, a separate 
overlay window will be displayed on which the parameter values can be changed directly. 
The new values are programmed to the device using the program parameters procedure as 
discussed in the previous chapter. As shown in the diagram, there is a different set of 
parameters for each of the heart rate zones. 
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Figure 12 Parameter Setup 
 
Setup ST Monitoring Heart Rate Zones 
From the ST Monitoring Setup window, if the user selects the heart rate zones 
panel, the ST Heart Rate Zones overlay window will be displayed. As shown in the 
diagram, this window only allows the user to change the minimum and maximum heart 
rates for the resting heart rate zone. The minimum and maximum heart rate values for the 
other three elevated heart rate zones will be set by the programmer application 
automatically based on the selected resting zone values. 
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Figure 13 Heart Rate Zone Setup 
 
 
Setup ST Monitoring representative beat 
Besides programming the parameters from the overlay windows, the user can also 
set the values for these parameters using the representative beat which is displayed to the 
user when the “Select New Beat” button is selected on the ST Monitoring Setup tab. 
The representative beat is a reference beat that can be used as the templates for 
setting other ST Monitoring parameters.  It needs to be selected from a patient’s stored 
EGM captured from intrinsic heart beat. If a reference waveform has not been selected, 
the user is given the option of selecting a waveform from three different sources of stored 
EGM: ST Baseline SEGM, ST Episode SEGM, or a real time captured and frozen EGM.  
The figure below shows the window displaying the ST Baseline SEGMs. The user 
can select one of the baselines to be the reference waveform from which the 
representative beat will be selected. The selected SEGM will be shown in the frozen 
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rhythm panel of the overlay window for beat selection. The selected beat will include 200 
ms worth of data before the R-peak and 400 ms worth of data following the R peak.  
 
 
 
Figure 14 Baseline Selection 
 
Positive Threshold and Negative threshold 
The positive and negative thresholds are programmable parameters. These are 
reference values used by the ST Monitoring algorithm for the following purposes: 
1. Baseline extraction. During baseline extraction, the ST deviation of the resting 
zone heart beats are compared to the thresholds, and the baseline is extracted 
only if the ST deviation is less than 50% of the programmed thresholds. 
2. ST-segment analysis. The ST motoring algorithm compare the ST deviation of 
a set of beats, and if the deviation is more than the thresholds, the current set is 
classified as an ST set.  If three consecutive sets are found to be shifted, an ST 
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episode is detected. The identified ST episode will be tracked if two 
consecutive un-shifted ST sets are detected. 
 
Suggested Thresholds 
Threshold values calculated based on the ST diagnostics data collected in the last 
seven days are presented to the user along with the programmed values.  User can 
directly select and program these recommended values to be used as the positive and 
negative thresholds. 
The suggested thresholds for the resting heart rate zone are displayed on several of 
the ST Monitoring setup windows, as shown in the diagram below.   User will be 
provided a reminder to use the suggested thresholds as the as the programmed thresholds 
as shown in the diagram below.  
.  
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Figure 15 Program Suggested Thresholds 
 
ST Monitoring diagnostics 
The ST Monitoring diagnostics data are presented in three panels: 
 
 
 
Figure 16 ST Trend panel 
 
The ST Deviation panel shows the deviation trend over a time period of either one 
month or six months. The vertical line shows the minimum and maximum ST Deviation 
for one day or one week. The small box between the min and max ST Deviation 
represents the ST deviation value of the histogram bin containing the largest number of 
analyzed beats per day. 
The Histogram Data panel shows the ST histogram line graph. The graph is 
plotted in “mV” unit on the X-Axis and number of beats in logarithmic scale on the Y-
Axis. The data for each heart rate zone is presented in a different color.  If the ST 
Histogram Data panel is selected, an overlay window is provided to the user to view the 
histogram for any day during the past seven days. 
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Figure 17 Histogram Overlay Window 
 
The Episode log panel contains the summary for the ST Episodes. Detail episode 
information is shown in a pop up window when the ST Episode Log panel is selected (see  
 
Figure 18 ST Episode Log 
 
By selecting the EGM icon on the table will open the ST Stored EGM Overlay. 
As shown in the overlay window, for each ST Episodes there are three associated Stored 
EGMs presented along the same time axis: ST Baseline SEGM, Max ST Shift SEGM, 
and the ST Episode Detection SEGM.  
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Figure 19 ST Episode Waveforms 
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V. CONCLUSION  
The ICD and the programmer software that support the St. Jude Medical’s ST 
segment monitoring capability was completed in the fourth quarter of 2008 and has been 
well received in the industry.  The programmer application has enabled the retrieval of 
the ST Monitoring data for the physician and gives physicians more comprehensive ST 
segment information over time.  This continuous ST-segment information provides early 
detection of potential fatal events and helps to capture cardiac episodes that are transient 
in nature. As a result, these data can lead to more timely diagnosis and therapy for 
patients, and possibly improve patient prognosis 
As reported by St. Jude  Medical in a press release, "The AnalyST ICD is the only 
implantable device that can provide me with ST segment monitoring reports via high-
quality, intracardiac electrograms, as well as additional ST segment diagnostic reports," 
said Professor Christian Hamm, Ph.D., from the Kerckhoff Klinik who implanted the first 
AnalyST ICD in Bad Nauheim, Germany. "This device provides me with new and 
valuable information about my patients' ST segments that is otherwise not available and 
helps me deliver better and timely care for my patients with arrhythmias and coronary 
artery disease." 
Currently, physicians are also able to review patients' ST segment changes using 
the remote transmissions from the St. Jude Medical Merlin@home transmitter, which is a 
wireless remote monitoring system placed in patients' homes. The transmitter sends the 
ST diagnostics report to Merlin.net, where the data will be stored in a database for an 
extended period of time. Physicians can retrieve and review the data at anytime from any 
place where internet service is available. Since the data is stored in a database, physicians 
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can review the historic data over a long period of time and compare the trend with the 
latest data retrieved. In addition, the Merlin.net system can be configured to provide 
notification service to the physician such that whenever critical ST episodes are detected 
an alert will be sent to the physician via email or phone call. 
 Currently the ST Monitoring feature is based on the intrinsic rhythm of the 
patient. The baseline stored EGM, ST-Shift measurement, and the threshold calculations 
are all based on intrinsic rhythm. To be able to correctly analyze ST-segment shift when 
paced heart beats are found in the EGM is a highly anticipated breakthrough.  
Understanding of the EGM patterns for ischemic events which involve ventricular pacing 
needs to be improved before a reliable algorithm can be made available in an implanted 
device. Nevertheless, good progress has been made in this area, and many articles have 
been published with suggested criteria for identifying myocardial infarction when 
ventricular paced rhythms are part of the waveform.   
Better sensing electrodes and lead technology will also be important to the 
enhancement of using ST-segment for monitoring of heart disease [16]. Increased 
understanding of the patterns of ST-segment shift will make it possible for implanted 
devices to provide more information regarding the disease, such as the location of the 
occluded vessel or the extent of the infracted cardiac muscle.  This type of information 
will be extremely helpful for planning and executing the revascularization procedure.  
It is important to continuously find ways for advancing the ST Monitoring 
algorithm in order to reduce risk wherever possible and contribute to successful outcomes 
for every patient.  
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